Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2026-01-02 @ 6:31 PM
Study NCT ID:
NCT00241657
Status:
COMPLETED
Last Update Posted:
2005-12-15
First Post:
2005-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immune Responses to BCG Vaccination in Malawi and the UK
Sponsor:
London School of Hygiene and Tropical Medicine
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2002-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
BCG vaccination has been found to provide greater protection against TB in the UK than in Malawi. This study compares immune responses in BCG-vaccinated and unvaccinated teenagers and young adults in Malawi and in the UK.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: